生命科学资讯

Sentynl gets the first US approval for rare copper absorption disease

Treg biotech Sonoma sheds staff after getting new CEO

Congress' biotech panel pitches FDA policy upgrades to help performance

Pretzel buys Rome and its ‘dark genome’ work

Nvidia-partnered startup reveals AI-generated enzymes for precise gene insertion

#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom

At FDA's request, Pfizer helps ease shortage of potential autism drug

FDA shares eased manufacturing rules for cell and gene therapies

FDA lifts partial hold on Merck, Daiichi's Phase 3 lung cancer study

Walmart makes tepid return to healthcare

Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report

AbbVie jumps into PD-1xVEGF bispecific race, pays $650M upfront to RemeGen

Eli Lilly, Nvidia sign five-year, up to $1B deal for AI laboratory

FDA again rejects Atara, Pierre Fabre's cell therapy for Epstein-Barr virus

Arkin Capital raises $100M to back a dozen early-stage biotechs

#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy

Novartis, SciNeuro to work together on preclinical amyloid-targeting drug for Alzheimer’s

Kinaset rakes in $103M to advance inhaled asthma drug

Signal Pulse Poll: What's the mood going into JPM?

Private and public biotechs go on $4.9B funding spree ahead of JPM